July 30, 2025, 10:30 AM -11:00 AM EDT
In today’s challenging biopharma world, treating your Target Product Profile (TPP) as a simple checklist is a recipe for disaster. It’s time to create a TPP that not only secures regulatory approval but also drives long-term differentiation, market access, and commercial success.
Join us to discover how early, cross-functional alignment around a future-proofed TPP can help your biopharma team proactively navigate evolving clinical, competitive, and payer dynamics. We’ll provide practical guidance and real-world insights to strengthen your decision-making, develop robust TPPs, and maximize asset value.
Leveraging Lumanity’s extensive experience, we’ll show you how a robust Early 360° TPP acts as a dynamic blueprint, guiding decisions from preclinical stages through commercialization. Our integrated, cross-functional approach helps teams shape strategies early for maximum commercial success by:
- Driving internal alignment across development and commercialization teams.
- Incorporating deep insights from evolving clinical, access, and competitive landscapes.
- Functioning as a living decision playbook adaptable at key milestones.
Moderators:
- Katie McCarthy, SVP and Practice Lead, Clinical & Regulatory Services, Lumanity
- Carolina Lahmann, PhD, VP, Strategy Consulting, Lumanity